Findings from NHO Annual Report 2011 Serious Adverse Reactions
Findings from NHO Annual Report 2011 Serious Adverse Reactions
Findings from NHO Annual Report 2011 Serious Adverse Reactions
SHOW LESS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Interactive - Case 2CXR showed – Widespread opacification inboth lungs – differential included pulmonaryodema perhaps due to fluid overload orinfection.TreatmentIV fluids discontinuedFurther dose of IV furosemide 40mgs stat26/11/2012 National Haemovigilance Office 19
Change language